Cargando…
Replicate Testing of Clinical Endpoints Can Prevent No-Go Decisions for Beneficial Vaccines
In vaccine efficacy trials, inaccurate counting of infection cases leads to systematic under-estimation—or “dilution”—of vaccine efficacy. In particular, if a sufficient fraction of observed cases are false positives, apparent efficacy will be greatly reduced, leading to unwarranted no-go decisions...
Autores principales: | Rosenbloom, Daniel I. S., Dudášová, Julie, Davis, Casey, Railkar, Radha A., Mehrotra, Nitin, Sachs, Jeffrey R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535203/ https://www.ncbi.nlm.nih.gov/pubmed/37766177 http://dx.doi.org/10.3390/vaccines11091501 |
Ejemplares similares
-
Beneficial microbes going underground of root immunity
por: Yu, Ke, et al.
Publicado: (2019) -
Controlling the Go / No-Go decision threshold in the striatum
por: Bahuguna, Jyotika, et al.
Publicado: (2013) -
Can ageing be beneficial?
por: Frenk, Stephen, et al.
Publicado: (2017) -
A method to estimate probability of disease and vaccine efficacy from clinical trial immunogenicity data
por: Dudášová, Julie, et al.
Publicado: (2021) -
Scientific and Societal Considerations in Selecting Assessment Endpoints for Environmental Decision Making
por: Strange, Elizabeth M., et al.
Publicado: (2002)